SM Hsieh, SC Chang, HY Cheng,
SR Shih… - Infectious Diseases and …, 2022 - Springer
… This study was an extension to the phase 1 main study, which was a prospective, open-label,
dose-escalation study to evaluate the safety and immunogenicity of a SARS-CoV-2 …